Parallax Volatility Advisers’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,072
Closed -$160K 3060
2022
Q3
$160K Buy
+5,072
New +$212K ﹤0.01% 2378
2016
Q1
Sell
-2
Closed -$7K 3071
2015
Q4
$7K Sell
2
-37
-95% -$121K ﹤0.01% 2720
2015
Q3
$63K Buy
+39
New +$195K ﹤0.01% 2113

Other funds holding IMUX

Parallax Volatility Advisers's IMUX Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of Immunic (IMUX) in Q4 2022, closing a stake of 5,072 shares — an estimated $160K sold.

Parallax Volatility Advisers first reported a position in IMUX in Q3 2015 and held it in 3 quarters. The position peaked at $160K in Q3 2022. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

  • Parallax Volatility Advisers reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,072 Immunic shares in Q4 2022, an estimated $160K.
  • Parallax Volatility Advisers first reported a position in Immunic in Q3 2015 and held it in 3 quarters.
  • Parallax Volatility Advisers's Immunic position peaked at $160K in Q3 2022.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.